Biotinidase deficiency: Genotype-biochemical phenotype association in Brazilian patients
Taciane Borsatto(Universidade Federal do Rio Grande do Sul), Ida Vanessa Döederlein Schwartz(Services Hospital), Maria Raquel Santos Carvalho(Ludwig-Maximilians-Universität München), Pablo Augusto de Souza Fonseca(Instituto de Ganadería de Montaña), Henk J. Blom(Erasmus MC), Charles Marques Lourenço(Universidade de São Paulo), Têmis Maria Félix(University of Iowa), José Simon Camelo(Clinics Hospital of Ribeirão Preto), Raquel Boy(Hospital Universitário Pedro Ernesto), Erlane Marques Ribeiro(Hospital Infantil Albert Sabin), Camila Matzenbacher Bittar(Universidade Federal do Rio Grande do Sul), Samyra Espindola Lima(Universidade de Brasília), Paula Frassinetti Vasconcelos de Medeiros(Universidade Federal de Campina Grande), Eurico Camargo Neto, Carolina Fischinger Moura de Souza(Hospital de Clínicas de Porto Alegre), Louise L. C. Pinto(Hospital Infantil Joana de Gusmão), Fernanda Sperb‐Ludwig(Universidade Federal do Rio Grande do Sul)
Cited by 29
Related Papers
Hyperhomocysteinemia as a Risk Factor for Deep-Vein Thrombosis
|New England Journal of Medicine|1996|1.1k
Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat
|New England Journal of Medicine|2016|555
A gene (RPGR) with homology to the RCC1 guanine nucleotide exchange factor is mutated in X–linked retinitis pigmentosa (RP3)
|Nature Genetics|1996|480
Enzyme replacement therapy for mucopolysaccharidosis VI: A phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension study
|The Journal of Pediatrics|2006|364